U.S. Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule Type, By Product, By Type, By Disease, By Formulation, By Age Group, By Route Of Administration, By End Market, By Country, And Segment Forecasts, 2024 - 2030

Market Segmentation

• U.S. Pharmaceutical Molecule Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Biologics & Biosimilars (Large Molecules)
    • Monoclonal Antibodies
    • Vaccines
    • Cell & Gene Therapy
    • Others
  • Conventional Drugs (Small Molecules)
• U.S. Pharmaceutical Product Outlook (Revenue, USD Billion, 2018 - 2030)
  • Branded
  • Generic
• U.S. Pharmaceutical Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Prescription
  • OTC
• U.S. Pharmaceutical Market: Therapeutic Category Outlook (Revenue, USD Billion, 2018 - 2030)
  • Oncology
  • Anti-infectives
  • Cardiovascular Diseases
  • CNS Disorders
  • Metabolic Disorders
  • GI Disorders
  • Respiratory Diseases
  • Others
• U.S. Pharmaceutical Market: Formulation Outlook (Revenue, USD Billion, 2018 - 2030)
  • Tablets
  • Capsules
  • Injectable
  • Sprays
  • Suspensions
  • Powders
  • Other Formulations
• U.S. Pharmaceutical Market: Age Group Outlook (Revenue, USD Billion, 2018 - 2030)
  • Children & Adolescents
  • Adults
  • Geriatric

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance